Experienced in Chondrosarcoma

Sharlene K. Gill

Vancouver, BC, CA 
Experienced in Chondrosarcoma
Vancouver, BC, CA 
OverviewLocationsClinical Research

Overview

Sharlene Gill practices in Vancouver, Canada. Ms. Gill is rated as an Experienced expert by MediFind in the treatment of Chondrosarcoma. Her top areas of expertise are Colorectal Cancer, Pancreatic Cancer, Liver Cancer, and Stomach Cancer.

Her clinical research consists of co-authoring 173 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 1 article in the study of Chondrosarcoma.

Gender
Female

Locations

Vancouver, BC, Canada
Other Locations
Ottawa, ON K1Z1A2, Canada
BC, Canada
Toronto, ON, Canada
Kelowna, BC V1V1V7, Canada
Kingston, ON, Canada
Surrey, BC, Canada

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

An Open-label, Multi-center, Phase 1b Study to Investigate the Safety and Tolerability of SLC-0111 (WBI-5111) in Combination With Gemcitabine in Metastatic Pancreatic Ductal Adenocarcinoma Subjects Positive for Carbonic Anhydrase IX
An Open-label, Multi-center, Phase 1b Study to Investigate the Safety and Tolerability of SLC-0111 (WBI-5111) in Combination With Gemcitabine in Metastatic Pancreatic Ductal Adenocarcinoma Subjects Positive for Carbonic Anhydrase IX
Enrollment Status: Terminated
Publish Date: May 24, 2024
Intervention Type: Drug
Study Drugs: SLC-0111, Gemcitabine
Study Phase: Phase 1/Phase 2
A Phase II Trial of the Effect of Perindopril on HFSR Incidence and Severity in Patients Receiving Regorafenib With Refractory Metastatic Colorectal Carcinoma (mCRC)
A Phase II Trial of the Effect of Perindopril on HFSR Incidence and Severity in Patients Receiving Regorafenib With Refractory Metastatic Colorectal Carcinoma (mCRC)
Enrollment Status: Completed
Publish Date: September 12, 2019
Intervention Type: Drug
Study Phase: Phase 2
View 1 Less Clinical Trial

172 Total Publications

Patient Preferences for Metastatic Colorectal Cancer Treatment: A Multi-method Approach Using Discrete Choice Experiments and Best-Worst Scaling.
Patient Preferences for Metastatic Colorectal Cancer Treatment: A Multi-method Approach Using Discrete Choice Experiments and Best-Worst Scaling.
Journal: The patient
Published: July 13, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Gill's expertise for a condition
ConditionClose
      View All 22 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile